NCT00981487View on ClinicalTrials.gov

Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Nausea
Interventions
DRUG

Ondansetron

24 mg one time

DRUG

Ondansetron

24 mg, on time in the am

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY